Business update - third quarter 2014
Genticel to meet institutional investors during the Large and Midcap Event in Paris, October 2 and 3, 2014
Business update and financial report June 30, 2014
Mary Tanner appointed to Genticel's Supervisory Board as independently-acting member
GENTICEL to participate in the Rodman and Renshaw investor conference in New York - from September 8 to 10
Genticel granted five new patents in the US and Asia during first half of 2014
Business Update - 2nd Quarter 2014
Genticel's Phase II study with Procervix passes the halfway mark for patient recruitment
Genticel meets US investors during "French Life Sciences Days" event in New York on June 25 et 26
Activity - First Quarter 2014
Genticel signs a liquidity contract with Oddo Corporate Finance
Total size of the initial public offering and communication of the terms and conditions of the stabilization transactions
Genticel lists on Euronext in Paris and Brussels
Genticel launches its initial public offering on the regulated market Euronext in Paris and Brussels
Genticel announces the registration of its "Document de base" in the context of the company's contemplated initial public offering on the Euronext Paris and Brussels regulated markets
Page 4 of 4
Ask us your questions
Suscribe to Newsletter